Growing evidence suggests that the gut microbiome and diabetes are intricately linked, with gut bacteria influencing glucose metabolism, insulin resistance, and inflammation. Dysbiosis, or microbial imbalance, has been associated with an increased risk of type 2 diabetes and metabolic dysfunction. Short-chain fatty acids produced by beneficial bacteria play a role in improving insulin sensitivity and regulating appetite. Probiotics, prebiotics, and dietary interventions targeting gut microbiota composition offer promising therapeutic potential. Advances in metagenomics and microbiome research continue to uncover mechanisms by which gut flora modulate metabolic health. Understanding these interactions may lead to novel microbiome-based strategies for diabetes prevention and treatment.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti